1) Client Alert | Capital Markets
SEC’s Division of Corporation
Finance Releases New Guidance
Related to Non-GAAP Financial
Measures
May 2016
Authors: Colin Diamond, David Johansen, Gary Kashar
On May 17, 2016, the Division of Corporation Finance of the Securities and
Exchange Commission (SEC) issued 12 new or revised Compliance and
Disclosure Interpretations (C&DIs) to its existing body of interpretations
relating to the use of non-GAAP financial information. Companies often
supplement their financial reporting under U.S. generally accepted accounting
principles (GAAP) with non-GAAP financial measures that management
believes more appropriately reflect the performance of their business.1 The
SEC permits companies to present non-GAAP financial measures under
certain circumstances, provided that such disclosures comply with Regulation
G in all cases and Item 10(e) of Regulation S-K when such information is
included or incorporated into a document that is filed with the SEC. In recent
years, the SEC has voiced concerns over how companies have been
presenting non-GAAP financial measures in their disclosures, such as
apparent “cherry-picking” of adjustments within a non-GAAP measure and the
use of adjustments to remove normal, cash operating expenses, or providing
per-share data for non-GAAP performance measures that look like liquidity
measures. While reaffirming the notion that non-GAAP financial measures can
provide useful information to investors, with its most recent guidance the SEC
has clearly signalled that non-GAAP financial information cannot be presented
more prominently than GAAP information or in a way that makes the relevant
disclosure misleading.
1
The same considerations set forth herein also generally apply to foreign private issuers who report their results of
operations using International Financial Reporting Standards (IFRS) or local GAAP. It should be noted that there are
limited exceptions from Regulation G and Item 10(e) of Regulation S-K for foreign private issuers with securities listed
on an exchange outside of the United States if the issuer does not report using U.S. GAAP, the disclosure is made
outside of the United States and is not targeted specifically at U.S. investors.
2) The C&DIs have immediate effect and may impact the quarterly earnings releases of some companies
significantly. In advance of their next earnings release, companies should evaluate their use and presentation
of non-GAAP financial measures in light of the new guidance, including disclosures about the reasons why
management believes that presentation of the non-GAAP financial measures provides useful information to
investors.
Instances When Non-GAAP Measures May Be Misleading
A number of the new and revised C&DIs explore instances when non-GAAP measures might be considered
misleading in violation of Rule 100(b) of Regulation G, which applies to a registrant’s public disclosures,
making clear that:
•
Certain adjustments, although not explicitly prohibited, could result in a non-GAAP measure that is
misleading, such as presenting a performance measure that excludes normal, recurring, cash operating
expenses necessary to operate a registrant’s business. (Question 100.01)
•
A non-GAAP measure might be misleading if it is presented inconsistently between periods, such as a
non-GAAP measure that adjusts a particular charge or gain in the current period but for which other,
similar charges or gains were not adjusted in prior periods. Further, depending on the significance of the
change, it may be necessary to recast prior measures to conform to the current presentation and place
the disclosure in the appropriate context. (Question 100.02)
•
A non-GAAP measure might be misleading if it excludes charges, but does not exclude any gains, such
as a non-GAAP measure that is adjusted only for non-recurring charges when there were non-recurring
gains that occurred during the same period. (Question 100.03)
•
Non-GAAP measures that accelerate revenue (as if the issuer earned the revenue when customers are
billed) are prohibited in all circumstances. The new guidance makes clear that non-GAAP revenue
measures that substitute individually tailored recognition and measurement methods for those of GAAP
are considered misleading under Rule 100(b). They are thus prohibited not only in documents filed with or
furnished to the SEC, but also elsewhere, such as on company websites. Non-GAAP measures that
substitute individually tailored recognition and measurement methods for other financial statement line
items may also violate Rule 100(b). (Question 100.04)
Per-Share Measures
The SEC also revised its prior guidance concerning the ability of public companies to disclose non-GAAP
financial measures on a per-share basis:
•
Only non-GAAP performance measures, not liquidity measures, should be presented on a per-share
basis. The guidance states that the staff will analyze whether a particular non-GAAP measure is
effectively a liquidity measure or a performance measure, rather than simply defer to management’s
characterization. (Question 102.05)
•
The use of the non-GAAP measure “free cash flow” is not prohibited under Item 10(e), but this is a liquidity
measure that cannot be presented on a per-share basis. Companies using this measure should include a
clear description of how it is calculated, along with the necessary reconciliation, and are cautioned to
avoid potentially misleading inferences about its usefulness. (Question 102.07)
•
Neither EBIT nor EBITDA may be presented on a per-share basis. (Question 103.02)
•
Real estate investment trusts may continue to present “funds from operations” (FFO), as defined by the
National Association of Real Estate Investment Trusts (NAREIT), as a performance measure on a pershare basis. (Question 102.01)
•
Companies presenting FFO on a basis other than as defined by NAREIT are cautioned that any
adjustments made to FFO must comply with the requirements of Item 10(e) for either a performance
measure or a liquidity measure, as applicable, some of which may trigger the prohibition on presenting
this measure on a per-share basis. (Question 102.02)
Client Alert
White & Case
2
3) Equal Prominence
Item 10(e) requires that when non-GAAP measures are used, the comparable GAAP measure must be
displayed with equal or greater prominence. While relative prominence depends on the facts and
circumstances in which the disclosure is made, the SEC offered the following examples of disclosure where
non-GAAP measures would be considered more prominent:
•
presenting a full income statement of non-GAAP measures or presenting a full non-GAAP income
statement when reconciling non-GAAP measures to the most directly comparable GAAP measures;
•
omitting comparable GAAP measures from an earnings release headline or caption that includes nonGAAP measures;
•
presenting a non-GAAP measure using a style of presentation (e.g., bold, larger font) that emphasizes the
non-GAAP measure over the comparable GAAP measure;
•
a non-GAAP measure that precedes the most directly comparable GAAP measure (including in an
earnings release headline or caption);
•
describing a non-GAAP measure as, for example, “record performance” or “exceptional” without at least
an equally prominent descriptive characterization of the comparable GAAP measure;
•
providing tabular disclosure of non-GAAP financial measures without preceding it with an equally
prominent tabular disclosure of the comparable GAAP measures or including the comparable GAAP
measures in the same table;
•
excluding a quantitative reconciliation with respect to a forward-looking non-GAAP measure in reliance on
the “unreasonable efforts” exception in Item 10(e)(1)(i)(B) without disclosing that fact and identifying the
information that is unavailable and its probable significance in a location of equal or greater prominence;
and
•
providing discussion and analysis of a non-GAAP measure without a similar discussion and analysis of
the comparable GAAP measure in a location with equal or greater prominence. (Question 102.10)
Adjustments for Non-recurring, Infrequent or Unusual Items
Item 10(e) prohibits adjusting a non-GAAP financial performance measure to eliminate or smooth items
identified as non-recurring, infrequent or unusual if the nature of the charge or gain is such that it is
reasonably likely to recur within two years or there was a similar charge or gain within the prior two years. The
new guidance makes clear that the prohibition applies to the description of the item as non-recurring,
infrequent or unusual. A registrant can still adjust for that item if it believes an adjustment is appropriate,
subject to Regulation G and the other requirements of Item 10(e). (Question 102.03)
Non-GAAP Financial Information Calculated Net of Taxes
The SEC’s updated guidance also indicates that any adjustments as a result of taxes should be shown and
explained as a separate adjustment in calculating a non-GAAP financial measure, rather than using
adjustments which themselves are net of the relevant effect of taxes. (Question 102.11)
Current State of Non-GAAP Reporting Regulations and Tips for
Compliance
Recent SEC staff remarks and the newly-issued guidance make clear that the SEC continues to pay close
attention to companies’ use of non-GAAP measures. In addition to assuring technical compliance with SEC
rules and guidance, management and audit committees should take this opportunity to re-examine their
companies’ use of non-GAAP financial measures in SEC filings and other public disclosures. Particular areas
of focus include:
•
Inconsistencies between public disclosures and filed documents. The SEC staff has indicated that when
reviewing a company’s periodic reports it will also review its earnings calls, press releases and other
information it makes publicly available, in order to identify any inconsistencies, and will issue comments
Client Alert
White & Case
3
4) on a company’s filed documents to bring the two types of information in line with each other and ensure
that the company provides consistent public disclosure.
•
Ensuring Non-GAAP measurements are appropriate and not misleading. Non-GAAP measurements
should be used to supplement, not supplant, information in the financial statements. Registrants should
take care to ensure that such non-GAAP measures would not be considered misleading. Preparers
should carefully consider whether significant adjustments to profitability outside of customary measures
such as EBITDA or non-recurring items, are appropriate and properly presented.
•
Management oversight of the use of non-GAAP measures. In a recent speech, SEC Chief Accountant
James Schnurr indicated that a company’s management and audit committee should increase their focus
on the use of non-GAAP measures beyond merely determining that they comply with SEC rules and
consider why the proposed non-GAAP measure is an appropriate way to measure the company’s
performance and is useful to investors. Companies should consider the application of disclosure controls
and procedures to non-GAAP measures.
•
Appropriate use of, and clear explanations regarding, non-GAAP measures. Recently, the staff has
issued a number of comments objecting to the use of, or disclosures regarding, non-GAAP measures, in
particular, companies’ disclosures as to why their non-GAAP measures are useful. Companies should
pay particular attention to providing thorough, thoughtful explanations for the use of non-GAAP measures.
White & Case LLP
1155 Avenue of the Americas
New York, New York 10036-2787
United States
T +1 212 819 8200
In this publication, White & Case means the international legal practice comprising White & Case LLP, a New York State registered
limited liability partnership, White & Case LLP, a limited liability partnership incorporated under English law and all other affiliated
partnerships, companies and entities.
This publication is prepared for the general information of our clients and other interested persons. It is not, and does not attempt to be,
comprehensive in nature. Due to the general nature of its content, it should not be regarded as legal advice.
Client Alert
White & Case
4